by Joe Dangor, Mayo Clinic Credit: Mayo Clinic Researchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancreatic ductal adenocarcinoma (PDAC). The researcher’s findings are published in Nature Cancer. “Pancreatic ductal adenocarcinoma is one of the most lethal cancers,” says the paper’s senior...
